Astellas Pharma's total assets FY 2013-2022

Published by
Catharina Klein,
Apr 29, 2024
In the fiscal year 2022, Astellas Pharma held assets worth approximately 2.46 trillion Japanese yen, the highest amount of the past decade. Within the observed period, figures increased steadily every year with only one minor exception in fiscal 2020.
The main areas of the Japanese pharmaceutical company include urology, immunology, cardiology, and infectious diseases.

Total assets of Astellas Pharma Inc. from fiscal year 2013 to 2022 (in trillion Japanese yen)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2023

Region

Japan

Survey time period

fiscal year 2013 to 2022; the company's fiscal year starts on April 1 of the stated year and ends on March 31 of the following year

Special properties

consolidated data

Supplementary notes

Astellas Pharma Inc. has adopted International Financial Reporting Standards (IFRS) since the fiscal year ended March 31, 2014. Figures up to fiscal year ended March 31 2014, are based on Japanese generally accepted accounting principles (J-GAAP).
Figures prior to FY 2021 come from the previous reporting.

100 Japanese yen equal 0.72 U.S. dollars or 0.67 euros as of June 2023.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Scandinavia "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Scandinavia

Pharmaceutical sales

8

Patents and clinical trials

6

Trade

5

Key players

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in SpainGlobal pharmaceutical industryDrug Store/Pharmacy Market in the U.S.Pharmaceutical industry in the U.S.Top pharmaceutical drugs
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu